Back to News
Market Impact: 0.1
Rapid Infection Diagnostics Appoints Mario Savarese to Strategic Advisory Board
Source: PR Newswire
Healthcare & BiotechManagement & Governance
Rapid Infection Diagnostics Inc. (RID), a Canadian life sciences company focused on metabolomics-based rapid infectious disease diagnosis, appointed Mario Savarese to its Strategic Advisory Board. The provided article excerpt contains no further details on Savarese or the appointment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.10
More News
- Zuckerberg told Meta directors he might leave California, where he could lose billions to a wealth tax. Meta answered with a new class of stock
- Elon Musk Thinks $3.5 Trillion Tesla-SpaceX Mashup Is a Good Idea
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- This wonky maneuver kept Mark Zuckerberg from fleeing a California billionaire tax
- Meta wants to pay for its broad AI buildout with a newly created class of stock
- Arcus Biosciences prices $250 million stock offering at $17.50
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Tools for Private Equity Due Diligence: A Buyer Workflow
- Weekly Update: In-App Tutorials, Futures Data, and Watchlist Enhancements